InMed Pharmaceuticals Inc. Annual Cost of Revenue in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate from 2022 to 2023.
  • InMed Pharmaceuticals Inc. Cost of Revenue for the quarter ending September 30, 2023 was $788K, a 235% increase year-over-year.
  • InMed Pharmaceuticals Inc. Cost of Revenue for the twelve months ending September 30, 2023 was $2.98M.
  • InMed Pharmaceuticals Inc. annual Cost of Revenue for 2023 was $2.42M, a 344% increase from 2022.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.42M +$1.88M +344% Jul 1, 2022 Jun 30, 2023 10-K 2023-09-29
2022 $546K Jul 1, 2021 Jun 30, 2022 10-K 2023-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.